Insider trade

Officer sold ~$704K of G shares in the open market

Traded Jan 13, 2026 · Filed Jan 14, 2026

Why it stands out

Genpact's Senior Vice President sold $704K of Genpact shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$703,855

Shares × reported transaction price

Timing vs results

68 days after results of Nov 6, 2025, 23 days before results of Feb 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	-0.1%	-0.5%	+0.4%
30 days	-18.4%	-1.4%	-17.0%
90 days	-21.6%	+1.1%	-22.7%
180 days	-36.1%	+8.6%	-44.7%

Past results only. Not a forecast.

The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.